{"id":"W2756935441","doi":"10.1158/1535-7163.mct-17-0170","title":"Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Olaparib; PARP inhibitor; Veliparib; Breast cancer; Cancer research; Triple-negative breast cancer; Cancer; Gene signature; Biology; DNA damage; Poly ADP ribose polymerase; Medicine; Molecular biology; Oncology; Internal medicine; Gene expression; Gene; Genetics; DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005560956,0.0004599993,0.0006262002,0.0002724036,0.0003033562,0.0001150614,0.0002319136,0.0003480376,0.000210608],"category_scores_gemma":[0.000107002,0.0004070478,0.0001452225,0.0005520573,0.0002249578,0.0001851238,0.0000647776,0.000678447,0.00001239777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001611215,"about_ca_system_score_gemma":0.001039043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005626223,"about_ca_topic_score_gemma":0.0009607796,"domain_scores_codex":[0.9971353,0.0003540473,0.0004350841,0.0006881237,0.0007458617,0.000641601],"domain_scores_gemma":[0.9977394,0.0001101858,0.0004216612,0.0009383175,0.0005274346,0.0002629855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01619626,0.0003698827,0.008917336,0.0000327508,0.0006696602,0.0006826791,0.001906049,0.0007648615,0.9619322,0.00005676293,0.0002405089,0.008231091],"study_design_scores_gemma":[0.0195556,0.0008457256,0.3549545,0.001465424,0.0003225893,0.00008153378,0.0002056532,0.0003819693,0.617866,0.0006369886,0.002740027,0.0009439539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9727645,0.001619476,0.001354709,0.02134886,0.0003610798,0.001527525,0.0005809863,0.0001181735,0.0003246925],"genre_scores_gemma":[0.9850677,0.0004052284,0.0003761126,0.01234796,0.0001960436,0.0008259833,0.00004386139,0.000131407,0.0006057643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3460371,"threshold_uncertainty_score":0.9998381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02957030360416233,"score_gpt":0.3234081071926166,"score_spread":0.2938378035884543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}